Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas
Curcumin (diferuloylmethane), a polyphenolic compound derived from the spice plant Curcuma longa, displays multiple actions on solid tumours including anti-angiogenic effects. Here we have studied in rodent and human pituitary tumour cells the influence of curcumin on the production of hypoxia induc...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2012
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| Sumario: | Curcumin (diferuloylmethane), a polyphenolic compound derived from the spice plant Curcuma longa, displays multiple actions on solid tumours including anti-angiogenic effects. Here we have studied in rodent and human pituitary tumour cells the influence of curcumin on the production of hypoxia inducible factor 1α (HIF1A) and vascular endothelial growth factor A (VEGFA), two key components involved in tumour neovascularisation through angiogenesis. Curcumin dose-dependently inhibited basal VEGFA secretion in corticotroph AtT20 mouse and lactosomatotroph GH3 rat pituitary tumour cells as well as in all human pituitary adenoma cell cultures (nZ32) studied. Under hypoxia-mimicking conditions (CoCl 2 treatment) in AtT20 and GH3 cells as well as in all human pituitary adenoma cell cultures (nZ8) studied, curcumin strongly suppressed the induction of mRNA synthesis and protein production of HIF1A, the regulated subunit of the hypoxia-induced transcription factor HIF1. Curcumin also blocked hypoxiainducedmRNAsynthesis and secretion ofVEGFAinGH3 cells and in all human pituitary adenoma cell cultures investigated (nZ18). Thus, curcumin may inhibit pituitary adenoma progression not only through previously demonstrated antiproliferative and pro-apoptotic actions but also by its suppressive effects on pituitary tumour neovascularisation. © 2012 Society for Endocrinology. |
|---|---|
| Bibliografía: | Abdel-Haq, H., Giacomelli, S., Palmery, M., Leone, M.G., Saso, L., Silvestrini, B., Aflatoxins inhibit prolactin secretion by rat pituitary cells in culture (2000) Drug and Chemical Toxicology, 23, pp. 381-386 Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumors (2009) Annual Review of Pathology, 4, pp. 97-126 Bae, M.K., Kim, S.H., Jeong, J.W., Lee, Y.M., Kim, H.S., Kim, S.R., Yun, I., Kim, K.W., Curcumin inhibits hypoxia-induced angiogenesis via down- regulation of HIF-1 (2006) Oncology Reports, 15, pp. 1557-1562 Bangaru, M.L., Woodliff, J., Raff, H., Kansra, S., Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease (2010) PLoS ONE, 5, pp. e9893 Bradford, M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Analytical Biochemistry, 72, pp. 248-254 Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., Holsboer, F., Arzt, E., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia (2007) Cell, 131, pp. 309-323 Carmeliet, P., Angiogenesis in health and disease (2003) Nature Medicine, 9, pp. 653-660 Carmeliet, P., VEGF as a key mediator of angiogenesis in cancer (2005) Oncology, 69, pp. 4-10 Choi, H., Chun, Y.S., Kim, S.W., Kim, M.S., Park, J.W., Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition (2006) Molecular Pharmacology, 70, pp. 1664-1671 Colao, A., Savastano, S., Medical treatment of prolactinomas (2011) Nature Reviews. Endocrinology, 7, pp. 267-278 Ebert, B.L., Bunn, H.F., Regulation of the erythropoietin gene (1999) Blood, 94, pp. 1864-1877 Farnoud, M.R., Kujas, M., Derome, P., Racadot, J., Peillon, F., Li, J.Y., Interactions between normal and tumoral tissues at the boundary of human pituitary adenomas (1994) Virchows Archiv: an International Journal of Pathology, 424, pp. 75-82 Ferrara, N., Vascular endothelial growth factor: basic science and clinical progress (2004) Endocrine Reviews, 25, pp. 581-611 Giustina, A., Bronstein, M.D., Casanueva, F.F., Chanson, P., Ghigo, E., Ho, K.K., Klibanski, A., Melmed, S., Current management practices for acromegaly: an international survey (2011) Pituitary, 14, pp. 125-133 Gloddek, J., Pagotto, U., Paez-Pereda, M., Arzt, E., Stalla, G.K., Renner, U., Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells (1999) Journal of Endocrinology, 160, pp. 483-490 Gospodarowicz, D., Abraham, J.A., Schilling, J., Isolation and characterization of a vascular cell mitogen produced by pituitary-derived folliculo stellate cells (1989) PNAS, 6, pp. 7311-7315 Gupta, S.C., Kim, J.H., Prasad, S., Aggarwal, B.B., Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals (2010) Cancer and Metastasis Reviews, 29, pp. 405-434 Gupta, S.C., Prasad, S., Kim, J.H., Patchva, S., Webb, L.J., Priyardasini, I.K., Aggarwal, B.B., Multitargeting by curcumin as revealed by molecular interaction studies (2011) Natural Product Reports, 28, pp. 1937-1955 Harris, A.L., Hypoxia - a key regulatory factor in tumour growth (2002) Nature Reviews. Cancer, 2, pp. 38-47 Hickey, M.M., Simon, M.C., Regulation of angiogenesis by hypoxia and hypoxia-inducible factors (2006) Current Topics in Developmental Biology, 76, pp. 217-257 Hori, S., Hayashi, N., Fukuoda, J., Kurimoto, M., Hamada, H., Miyajima, K., Nagai, S., Endo, S., Folliculostellate cell tumor in the pituitary gland (2009) Neuropathology, 29, pp. 78-80 Iwaki, T., Kondo, A., Takeshita, I., Nakagaki, H., Kitamura, K., Tateishi, J., Proliferating potential of folliculo-stellate cells in human pituitary adenomas, Immunohistochemical and electron microscopic analysis (1986) Acta Neuropathologica, 71, pp. 233-242 Jung, H.J., Kim, J.H., Shim, J.S., Kwon, H.J., A novel Ca2C/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor (2010) Journal of Biological Chemistry, 285, pp. 25867-25874 Kim, K., Yoshida, D., Teramoto, A., Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in pituitary adenomas (2005) Endocrine Pathology, 16, pp. 115-121 Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins (2008) Cancer Letters, 269, pp. 199-225 Lafont, C., Desarmenien, M.G., Cassou, M., Molino, F., Lecoq, J., Hodson, D., Lacampagne, A., Carmignac, D., Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function (2010) PNAS, 107, pp. 4465-4470 Lloyd, R.V., Scheithauer, B.W., Kuroki, T., Vidal, S., Kovacs, K., Stefaneanu, L., Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas (1999) Endocrine Pathology, 10, pp. 229-235 Lohrer, P., Gloddek, J., Hopfner, U., Losa, M., Uhl, E., Pagotto, U., Stalla, G.K., Renner, U., Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro (2001) Neuroendocrinology, 7, pp. 95-105 Masson, N., Ratcliffe, P.J., HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels (2003) Journal of Cell Science, 116, pp. 3041-3049 Melmed, S., Pathogenesis of pituitary tumors (2011) Nature Reviews. Endocrinology, 7, pp. 257-266 Miller, M., Chen, S., Woodliff, J., Kansra, S., Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells (2008) Endocrinology, 149, pp. 4158-4167 Nagasawa, H., The in vitro and in vivo effects of dimethyl sulfoxide on the pituitary secretion of growth hormone and prolactin in mice (1983) Annals of the New York Academy of Sciences, 411, pp. 34-42 Onofri, C., Theodoropoulou, M., Losa, M., Uhl, E., Lange, M., Arzt, E., Stalla, G.K., Renner, U., Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours (2006) Journal of Endocrinology, 191, pp. 249-261 Pagotto, U., Arzberger, T., Theodoropoulou, M., Grübler, Y., Pantaloni, C., Saeger, W., Losa, M., Spengler, D., The expression of the antiproliferative gene ZAC is lost or highly reduced in non-functioning pituitary adenomas (2000) Cancer Research, 60, pp. 6794-6799 Perez-Castro, C., Renner, U., Haedo, M.R., Stalla, G.K., Arzt, E., Cellular and molecular specificity of pituitary gland physiology (2012) Physiological Reviews, 92, pp. 1-38 Raverot, G., Sturm, N., de Fraipont, F., Muller, M., Salenave, S., Caron, P., Chabre, O., Assaker, R., Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience (2010) Journal of Clinical Endocrinology and Metabolism, 95, pp. 4592-4599 Renner, U., Arzberger, T., Pagotto, U., Leingruber, S., Uhl, E., Müller, A., Lange, M., Stalla, G.K., Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically non-functioning pituitary adenomas (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1368-1375 Renner, U., Lohrer, P., Schaaf, L., Feirer, M., Schmitt, K., Onofri, C., Arzt, E., Stalla, G.K., Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells (2002) Endocrinology, 143, pp. 3759-3765 Renner, U., Paez-Pereda, M., Arzt, E., Stalla, G.K., Growth factors and cytokines: function and molecular regulation in pituitary adenomas (2004) Frontiers of Hormone Research, 32, pp. 96-109 Saeger, W., Lüdecke, D.K., Buchfelder, M., Fahlbusch, R., Quabbe, H.J., Petersenn, S., Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry (2007) European Journal of Endocrinology, 156, pp. 203-216 Santos, N.C., Figueira-Coelho, J., Martins-Silva, J., Saldanha, C., Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects (2003) Biochemical Pharmacology, 65, pp. 1035-1041 Schaaf, C., Shan, B., Buchfelder, M., Losa, M., Kreutzer, J., Rachinger, W., Stalla, G.K., Perone, M.J., Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo (2009) Endocrine-Related Cancer, 16, pp. 1339-1350 Schaaf, C., Shan, B., Onofri, C., Stalla, G.K., Arzt, E., Schilling, T., Perone, M.J., Renner, U., Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells (2010) Neuroendocrinology, 91, pp. 200-210 Shahani, K., Swaminathan, S.K., Freeman, D., Blum, A., Ma, L., Panyam, J., Injectable sustained release microparticles of curcumin: a new concept for cancer prevention (2010) Cancer Research, 70, pp. 4443-4452 Shan, B., Gerez, J., Haedo, M., Fuertes, M., Theodoropoulou, M., Buchfelder, M., Losa, M., Renner, U., RSUME is implicated in HIF-1-induced VEGFA production in pituitary tumour cells (2012) Endocrine-Related Cancer, 19, pp. 13-27 Shehzad, A., Wahid, F., Lee, Y.S., Curcumin in cancer prevention: molecular targets, pharmacokinetics, bioavailability, and clinical targets (2010) Archiv der Pharmazie, 9, pp. 489-499 Shih, S.C., Claffey, K.P., Role of AP-1 and HIF-1 transcription factors in TGF-β activation of VEGF expression (2001) Growth Factors, 19, pp. 19-34 Ströfer, M., Jelkmann, W., Depping, R., Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells (2011) The role of HIF. Strahlentherapie und Onkologie, 187, pp. 393-400 Thomas, S.L., Zhong, D., Zhou, W., Malik, S., Liotta, D., Snyder, J.P., Hamel, E., Giannakakou, P., EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 (2008) Cell Cycle, 7, pp. 2409-2417 Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Harris, A.L., Wass, J., Angiogenesis in pituitary adenomas and the normal pituitary gland (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 1159-1162 Viacava, P., Gasperi, M., Acerbi, G., Manetti, L., Cecconi, E., Bonadio, A.G., Naccarato, A.G., Lupi, I., Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas (2003) Journal of Endocrinological Investigation, 26, pp. 23-28 Vidal, S., Horvath, E., Kovacs, K., Kuroki, T., Lloyd, R.V., Scheithauer, B.W., Expression of hypoxia-inducible factor-1α (HIF-1α) in pituitary tumours (2003) Histology and Histopathology, 18, pp. 679-686 Wahl, O., Oswald, M., Tretzel, L., Herres, E., Arend, J., Efferth, T., Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products (2011) Current Medicinal Chemistry, 18, pp. 3136-3155 Webb, J.D., Coleman, M.L., Pugh, C.W., Hypoxia, hypoxia-inducible factors (HIF) (2009) HIF hydroxylases and oxygen sensing. Cellular and Molecular Life Sciences, 66, pp. 3539-3554 Wei, W., Yu, X.D., Hypoxia-inducible factors: cross-talk between their protein stability and protein degradation (2007) Cancer Letters, 257, pp. 145-156 Yadav, V.R., Aggarwal, B.B., Curcumin: a component of the golden spice, targets multiple angiogenic pathways (2011) Cancer Biology & Therapy, 11, pp. 236-241 Yuan, Y., Hilliard, G., Ferguson, T., Millhorn, D.E., Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α (2003) Journal of Biological Chemistry, 278, pp. 15911-15916 |
| ISSN: | 00220795 |
| DOI: | 10.1530/JOE-12-0207 |